Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma
- 1 July 2017
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 398, 12-21
- https://doi.org/10.1016/j.canlet.2017.03.038
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81572457, 81272394)
This publication has 47 references indexed in Scilit:
- miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cellsOncotarget, 2015
- Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinomaCancer Letters, 2015
- Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular CarcinomaCancer Research, 2015
- Nuclear factor kappa B–mediated CD47 up‐regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in miceHepatology, 2015
- Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5+ liver cancer initiating cells by suppressing negative regulators of β-catenin signalingOncogene, 2015
- Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem CellsCancer Research, 2014
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approachesCancer Letters, 2014
- Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44+ gastric cancer cells via attenuating Wnt signalingThe Esophagus, 2012
- HCC and angiogenesis: possible targets and future directionsNature Reviews Clinical Oncology, 2011